Navigation Links
Spanish researchers design biomarkers for the detection of dengue and West Nile virus
Date:2/6/2013

Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by the bite of a mosquito. These biomarkers can be used to identify these viral diseases, which affect millions of people worldwide.

The University of Granada spin-off Rekom Biotech is a biotech company composed of professionals from the private sector and from the University of Granada. Rekom Biotech is focused in the design and production of biological material used in diagnostic tests called "recombinant antigents". These antigens are markers of a variety of diseases caused by viruses, bacteria, fungi and parasites.

Saving Lives and Money

These products can be used in the different in vitro diagnostic platforms or systems. Specifically, the biomarkers designed at the University of Granada spin off "might serve to design diagnostic tests that will help save lives and money", states the Rekom Biotech general manager, Ana Camacho Pez.

The Andalusian company also supplies other services based on the design and production of proteins and other molecular biology tools.

Currently, Rekom Biotech supplies white label recombinant antigens to two American companies, and will start supplying biological material to a German company soon. Their catalogue includes more than 50 recombinant antigens for the in vitro diagnosis of a range of infectious diseases. This company conducts its R&D activities at the Health Technology Park in Granada, Spain.


'/>"/>

Contact: Ana Camacho Pez. Rekom Biotech UGR
agcamacho@rekombiotech.com
34-958-637-085
University of Granada
Source:Eurekalert  

Page: 1

Related biology news :

1. Spanish consumers prefer national fish
2. Spanish scientist participate in the most comprehensive study ever done on ice
3. Spanish researcher releases a video showing a beetle from the inside
4. UT Dallas researchers pushing the boundaries of virtual reality
5. Polar bear researchers urge governments to act now and save the species
6. Pitt researchers reveal mechanism to halt cancer cell growth, discover potential therapy
7. Researchers discover mutations linked to relapse of childhood leukemia
8. Caught in the act: Researchers capture key moments in cell death
9. Researchers harness nature to produce the fuel of the future
10. U. of Minn. researchers unveil first artificial enzyme created by evolution in a test tube
11. Prehistoric humans not wiped out by comet, says researchers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spanish researchers design biomarkers for the detection of dengue and West Nile virus
(Date:11/5/2019)... ... 2019 , ... Dr. Lauren Kopp celebrates one year ... WA, including porcelain veneers , smile makeovers, dental implants, and the Bioclear ... Dr. Kopp is passionate about serving her Seattle community with empathy and precision ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards ... analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate ... , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal ...
(Date:10/30/2019)... ... 30, 2019 , ... Amberdata Inc., the leading blockchain and ... Capital, DF Capital, Rising Tide Fund, and HWVP. The new investment will ... its position as the leading data provider of institutional-grade blockchain and cryptoasset data. ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... Md. (PRWEB) , ... October 09, 2019 , ... ... announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote ... 27–30 October 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist ...
(Date:10/10/2019)... ... October 10, 2019 , ... VirTrial ... clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual ... trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical ...
(Date:10/8/2019)... ... ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the recent patenting ... approved in the U.S. in 2017, the new patent covers the company’s unique technology ... technology in the U.S. as the AlphaSTEM Test™. The new patent will support ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... a new life sciences leadership firm that is enabling clinical program outsourcing success ... , Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings ...
Breaking Biology Technology: